Selonterra announces grant of United States patent on original discoveries in Alzheimer’s disease

SAN MATEO, Calif., Aug. 19, 2025 /PRNewswire/ — Selonterra, Inc. (www.selonterra.com), a biotechnology company developing transformative therapies for neurodegenerative disorders announces that the U.S. Patent and Trademark Office (USPTO) has granted the U.S. Patent No. 12,385,093…